UK markets close in 3 hours 58 minutes

KemPharm Inc (1GDA.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
4.30000.0000 (0.00%)
As of 08:18AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
16,563
10,161
28,650
13,288
12,839
Cost of revenue
1,089
222
2,059
1,305
2,945
Gross profit
15,474
9,939
26,591
11,983
9,894
Operating expenses
Research development
34,926
19,803
10,161
8,843
19,415
Selling general and administrative
24,734
15,038
8,701
7,921
10,816
Total operating expenses
59,660
34,841
18,862
16,764
30,231
Operating income or loss
-44,186
-24,902
7,729
-4,781
-20,337
Interest expense
915
335
376
7,090
6,514
Total other income/expenses net
541
-3,081
-16,135
-1,012
1,998
Income before tax
-39,951
-26,805
-8,521
-12,794
-24,544
Income tax expense
-34
-33
34
-34
-22
Income from continuing operations
-39,917
-26,772
-8,555
-12,760
-24,522
Net income
-39,917
-26,772
-8,555
-12,760
-24,522
Net income available to common shareholders
-39,917
-26,772
-62,897
-12,760
-24,522
Basic EPS
-1.16
-0.78
-2.11
-3.21
-13.28
Diluted EPS
-1.16
-0.78
-2.11
-3.21
-13.28
Basic average shares
34,400
34,489
29,766
3,981
1,853
Diluted average shares
36,212
34,489
29,766
3,981
1,853